Reported about 2 months ago
For the first time, Medicare has negotiated lower prices for ten high-cost prescription drugs, set to take effect in 2026, with reductions of nearly 79%. The affected medications include Stelara, Xarelto, Eliquis, and others, providing significant savings for beneficiaries enrolled in Medicare Part D. This unprecedented move was detailed by Yahoo Finance's health reporter, Anjalee Khemlani, with insights from Dr. Meena Seshamani.
Source: YAHOO